Malat1 promotes macrophage-associated inflammation by increasing PPAR-γ methylation through binding to EZH2 in acute myocardial infarction

被引:4
|
作者
Chang, Fangyuan [1 ]
Wang, Chunxiao [2 ]
Zheng, Ping [3 ]
Liu, Zhen [1 ]
Wang, Hua [2 ]
Gong, Lei [2 ]
Dong, Haibin [2 ]
Jing, Yanyan [2 ]
Mi, Shaohua [2 ]
Xie, Zan [2 ]
Ge, Peipei [2 ]
Yang, Jun [4 ]
Zhong, Lin [4 ]
机构
[1] Shandong Univ, Sch Med, Jinan 250012, Peoples R China
[2] Yantai Yuhuangding Hosp, Dept Cardiol, Yantai 264000, Peoples R China
[3] Shandong First Med Univ, Shandong Canc Hosp & Inst, Dept Clin Lab, Shandong Canc Hosp, Jinan 250117, Peoples R China
[4] Shandong Univ, Yantai Yuhuangding Hosp, Dept Cardiol, Jinan 250012, Peoples R China
基金
中国国家自然科学基金;
关键词
Acute myocardial infarction; Inflammatory microenvironment; Macrophages; Long non -coding RNA; Epigenetic modification; NONCODING RNA MALAT1; LNCRNA MALAT1; APOPTOSIS; PATHWAY; RATS;
D O I
10.1016/j.intimp.2023.110695
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The inflammatory microenvironment of macrophage plays an important role in acute myocardial infarction (AMI), but the regulatory mechanism is unknown. Here, we aimed to investigate the role of Malat1 on inflammation microenvironment of macrophage in AMI. Our study found that Malat1 expression was increased in AMI, which mainly expressed in macrophages. Malat1 inhibition improved collagen deposition and inflammation in infarcted heart. In vitro, Malat1 inhibition evidently reduced macrophage-associated inflammation. The results from ribonucleic acid pull-down (RNA pull-down) and RNA Immunoprecipitation (RIP) assay demonstrated that Malat1 directly binds to EZH2. Malat1 and EZH2 complex could increase histone H3K27me3 expression and further inhibit the production of PPAR-gamma. In vivo, inhibition of Malat1 also leaded to the down -regulation of both EZH2 and H3K27me3, as well as up-regulation of PPAR-gamma in infarcted heart. Therefore, these findings demonstrate a novel mechanism of Malat1 on inflammation microenvironment of macrophage in AMI, which provide a new target for its treatment.
引用
收藏
页数:8
相关论文
共 11 条
  • [1] MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2
    Huo, Yanqing
    Li, Qingbo
    Wang, Xiqian
    Jiao, Xiejia
    Zheng, Jiachun
    Li, Zhiqiang
    Pan, Xiaohan
    ONCOTARGET, 2017, 8 (29) : 46993 - 47006
  • [2] MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2
    Li, Peilong
    Zhang, Xin
    Wang, Haiyan
    Wang, Lili
    Liu, Tong
    Du, Lutao
    Yang, Yongmei
    Wang, Chuanxin
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (04) : 739 - 751
  • [3] Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205
    Hirata, Hiroshi
    Hinoda, Yuji
    Shahryari, Varahram
    Deng, Guoren
    Nakajima, Koichi
    Tabatabai, Z. Laura
    Ishii, Nobuhisa
    Dahiya, Rajvir
    CANCER RESEARCH, 2015, 75 (07) : 1322 - 1331
  • [4] MALAT1 is Associated with Poor Response to Oxaliplatin-based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2 (vol 16, pg 739, 2017)
    Li, Peilong
    Zhang, Xin
    Wang, Haiyan
    Wang, Lili
    Liu, Tong
    Du, Lutao
    Yang, Yongmei
    Wang, Chuanxin
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (02) : 451 - 451
  • [5] LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of EZH2
    Duan, Yuansheng
    Yue, Kai
    Ye, Beibei
    Chen, Peng
    Zhang, Jin
    He, Qinghua
    Wu, Yue
    Lai, Qingchuan
    Li, Hong
    Wu, Yansheng
    Jing, Chao
    Wang, Xudong
    CELL DEATH & DISEASE, 2023, 14 (02)
  • [6] LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of EZH2
    Yuansheng Duan
    Kai Yue
    Beibei Ye
    Peng Chen
    Jin Zhang
    Qinghua He
    Yue Wu
    Qingchuan Lai
    Hong Li
    Yansheng Wu
    Chao Jing
    Xudong Wang
    Cell Death & Disease, 14
  • [7] NCAPD3 promotes prostate cancer progression by up-regulating EZH2 and MALAT1 through STAT3 and E2F1
    Jing, Zuolei
    Liu, Qianmei
    Xie, Wanlin
    Wei, Yong
    Liu, Jiale
    Zhang, Yi
    Zuo, Wenren
    Lu, Shan
    Zhu, Qingyi
    Liu, Ping
    CELLULAR SIGNALLING, 2022, 92
  • [8] Correction: LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of EZH2
    Yuansheng Duan
    Kai Yue
    Beibei Ye
    Peng Chen
    Jin Zhang
    Qinghua He
    Yue Wu
    Qingchuan Lai
    Hong Li
    Yansheng Wu
    Chao Jing
    Xudong Wang
    Cell Death & Disease, 14
  • [9] LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of EZH2 (vol 14, 522, 2023)
    Duan, Yuansheng
    Yue, Kai
    Ye, Beibei
    Chen, Peng
    Zhang, Jin
    He, Qinghua
    Wu, Yue
    Lai, Qingchuan
    Li, Hong
    Wu, Yansheng
    Jing, Chao
    Wang, Xudong
    CELL DEATH & DISEASE, 2023, 14 (08)
  • [10] MiR-130b promotes obesity associated adipose tissue inflammation and insulin resistance in diabetes mice through alleviating M2 macrophage polarization via repression of PPAR-γ
    Zhang, Min
    Zhou, Zhongqi
    Wang, Jinguang
    Li, Shufa
    IMMUNOLOGY LETTERS, 2016, 180 : 1 - 8